Q32 Bio (QTTB) EBITDA Margin (QoQ) (2018 - 2023)
Q32 Bio (QTTB) EBITDA Margin (QoQ) (2018 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Q32 Bio | 215.94 Mn | 165.19 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 231,719.00 |
| Sep 30, 2023 | -19,248.00 |
| Jun 30, 2023 | 2,320.00 |
| Mar 31, 2023 | 405,081.00 |
| Dec 31, 2022 | -20,349.00 |
| Sep 30, 2022 | -56,796.00 |
| Jun 30, 2022 | 116,097.00 |
| Mar 31, 2022 | -49,788.00 |
| Dec 31, 2021 | -236,432.00 |
| Sep 30, 2021 | -43,134.00 |
| Jun 30, 2021 | -139,319.00 |
| Mar 31, 2021 | 303,723.00 |
| Dec 31, 2020 | 194,540.00 |
| Sep 30, 2020 | 130,935.00 |
| Jun 30, 2020 | -8,964.00 |
| Mar 31, 2020 | -166,634.00 |
| Dec 31, 2019 | 255,500.00 |
| Sep 30, 2019 | 4,118.00 |
| Jun 30, 2019 | 216,885.00 |
| Mar 31, 2019 | -761,819.00 |